Joy Scheidell
Joy D. Scheidell, PhD, MPH
University of Central Florida - Assistant Professor, Department of Health Sciences
PhD, Epidemiology, New York University
MPH, Epidemiology, University of Florida
BS, Community Health, Florida Gulf Coast University
Research Interests
Sexual and reproductive health, criminal justice involvement, substance use, mental health, health inequities
Joy Scheidell is an epidemiologist and Assistant Professor in the Department of Health Sciences at the University of Central Florida. She received her PhD in Epidemiology from NYU and an MPH in Epidemiology from the University of Florida. She is a former predoctoral fellow of the NIDA-funded Behavioral Sciences Training in Drug Abuse Research Program (T32 DA7233) and scholar in the NIDA Diversity Scholars Network 2022 cohort. Dr. Scheidell’s research seeks to understand the intersections of mental health, substance use, and sexual and reproductive health, with a specific focus on vulnerable and marginalized populations. In addition to conducting her research, Dr. Scheidell is a devoted instructor of epidemiologic and population health research methods.
Principal Investigator, Influence of Substance Use Treatment and Harm Reduction Engagement on Sexual Health among People Who Use Illicit Opioids in New York City. Completed
Principal Investigator, Racial/Ethnic Inequities in Treatment for Women with Opioid Use Disorder and Associations with Health. Completed


Khan MR, Hoff L, Elliott L, Scheidell JD, Pamplin JR, Townsend TN, Irvine NM, Bennett AS (2023).
Racial/ethnic disparities in opioid overdose prevention: Comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City
Harm Reduction Journal, 21 (1), 24. doi: 10.1186/s12954-023-00736-7. PMCID: PMC9959933.

Feelemyer JP, Richard E, Khan MR, Scheidell JD, Caniglia EC, Manandhar-Sasaki P, Ban KF, Charles D, Braithwaite RS (2023).
Does the association between stimulant use and high risk sexual behavior vary by injection drug use, sexual minority status, or HIV infection status? A meta-analysis
AIDS and Behavior [Epub 2023 Feb 14]. doi: 10.1007/s10461-023-04012-4.

Remch M, Scheidell JD, Cleland CM, Turpin R, Duncan DT, Dyer TT, Kaufman JS, Mazumdar M, Brewer R, Feelemyer J, Mayer KH, Khan MR (2023).
Mediation of the effect of incarceration on selling sex among Black sexual minority men and Black transgender women in the HPTN 061 study
AIDS and Behavior [Epub 2023 Feb 6]. doi: 10.1007/s10461-023-04003-5.

Bershteyn A, Richard E, Zhou Q, Khan MR, Scheidell JD, Manandhar-Sasaki P, Ban K, Crystal S, Gordon AJ, Justice AC, Bryant KJ, Braithwaite RS (2023).
Potential health benefits of integrated screening strategies for alcohol, tobacco, other substance use, depression, anxiety, and chronic pain among people living with HIV in the USA: A mathematical modelling study
Lancet HIV, 10 (2), e118-e125. doi: 10.1016/S2352-3018(22)00361-7.

Scheidell JD, Townsend T, Ban KF, Caniglia EC, Charles D, Edelman EJ, Marshall BDL, Gordon AJ, Justice AC, Braithwaite RS, Khan MR (2023).
Cessation of self-reported opioid use and impacts on co-occurring health conditions
Drug and Alcohol Dependence, 242, 109712. doi: 10.1016/j.drugalcdep.2022.109712.


Scheidell JD, Lejuez CW, Golin CE, Hobbs MM, Wohl DA, Adimora AA, Khan MR (2016).
Borderline personality disorder symptom severity and sexually transmitted infection and HIV risk in African American incarcerated men
Sexually Transmitted Diseases, 43 (5), 317-323. doi: 10.1097/OLQ.0000000000000433. PMCID: PMC4840466.

Ms. Scheidell's MyBibliography Profile